← FDA DRUG APPROVALS

FDA ANDA · ANDA090612

CHLOROQUINE PHOSPHATE

Sponsor: NATCO PHARMA LTD

APPLICATION
ANDA090612
TYPE
ANDA
ORIGINAL APPROVAL
2011-01-21
LATEST ACTION
2023-07-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CHLOROQUINE PHOSPHATEPrescription
CHLOROQUINE PHOSPHATE 500MG · TABLET · ORAL

Approval history

2023-07-24Labeling · Supplement 6 · standardAP
2022-05-03Labeling · Supplement 5 · standardAP
2022-03-17Labeling · Supplement 4 · standardAP
2022-03-17Labeling · Supplement 3 · standardAP
2011-01-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →